Home › Geographic Atrophy › Ohio › Cincinnati
Geographic Atrophy clinical trials in Cincinnati, OH
3 studies for Geographic Atrophy are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- Cincinnati Eye Institute, Cincinnati
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
RecruitingPhase 2
- Cincinnati Eye Institute, Blue Ash · 10 mi away
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RecruitingPhase 2/3
- Cincinnati Eye Institute, Cincinnati
Geographic Atrophy trials in other cities
- Dallas, TX8 studies
- Reno, NV8 studies
- Santa Monica, CA7 studies
- Austin, TX7 studies
- Naperville, IL6 studies
- Houston, TX6 studies
- Baltimore, MD6 studies
- Cleveland, OH6 studies
- The Woodlands, TX6 studies
- Hagerstown, MD5 studies
- Erie, PA5 studies
- San Antonio, TX5 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer35 studies
- Cancer (all types)28 studies
- Breast Cancer25 studies
- Heart Failure24 studies
- Colorectal Cancer21 studies
- Acute Myeloid Leukemia20 studies
- Metastatic Cancer20 studies
- Lung Cancer19 studies
- Obesity19 studies
- Ovarian Cancer19 studies
- Prostate Cancer18 studies
- Melanoma17 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.